A carregar...
Compliance with RSV prophylaxis: Global physicians’ perspectives
Respiratory syncytial virus (RSV) is a significant cause of morbidity in high-risk infants. Palivizumab is proven to prevent serious RSV disease, but compliance with prophylaxis (monthly doses during the RSV season) is essential to ensure protection. We invited 453 pediatricians to participate in a...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2778415/ https://ncbi.nlm.nih.gov/pubmed/19936162 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|